Drug points: Hepatotoxicity associated with zolpidem treatment
- 1 May 1999
- Vol. 318 (7192) , 1179
- https://doi.org/10.1136/bmj.318.7192.1179
Abstract
References 1.↵ Ausset P, Malavialle P, Vallet A, Minemont G, Le Bail B, Dumas F, et al .Hépatite subfulminante à l'alpidem traitée par transplantation hépatique.Gastroentérologie Clinique et Biologique1995; 19:222–235. 2.↵ Baty V .Hépatite imputable à l'alpidem (Ananxyl), quatre cas dont un mortel. Gastroentérologie Clinique et Biologique1994; 18:1129–1131. 3.↵ Queneau PE, Koch S, Hrusovsky S, Miguet JP . Zolpidem. Cytolytic hepatitis related to zolpidem. First international symposium on hepatology and clinical pharmacology liver and drugs 1994;38. (abstract). [Available on Medline.] 4.↵ Garnier R .Acute zolpidem poisoning—analysis of 344 cases.Clin Toxicol1994; 32:391–404. 5.↵ Benichou C .Criteria of drug-induced liver disorders. Report of an international consensus meetingJ Hepatol1990; 11:272–276.This publication has 4 references indexed in Scilit:
- [Subfulminant hepatitis caused by alpidem and treated by liver transplantation].1995
- [Hepatitis induced by alpidem (Ananxyl). Four cases, one of them fatal].1994
- Acute Zolpidem Poisoning Analysis of 344 CasesJournal of Toxicology: Clinical Toxicology, 1994
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990